BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Mologen AG 

P.O. Box 332140

Berlin    D - 14180  Germany
Phone: 49-0-30-857-576-0 Fax: 49-0-30-857-576-50


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Gene Therapy





 Company News
Mologen AG (MOLGF.PK): Presentation On IMPACT Study At ESMO Symposium On Immuno-Oncology 11/17/2014 1:27:53 PM
Mologen AG (MOLGF.PK) Publishes Nine Month Report For 2014: Launch Of Pivotal Study For The Cancer Immunotherapy MGN1703 11/13/2014 9:51:51 AM
Mologen AG (MOLGF.PK): Presentation Of DNA Vaccine Against Leishmaniasis At IMED 2014 11/3/2014 12:54:28 PM
Mologen AG (MOLGF.PK): Successful Investigator Meetings For IMPALA Colorectal Cancer Trial 10/20/2014 11:08:34 AM
Mologen AG (MOLGF.PK) Presents EnanDIM: A New Generation Of Immunomodulators 10/14/2014 10:53:05 AM
Mologen AG (MOLGF.PK): Three Poster Presentations At ESMO 2014 Congress 9/18/2014 1:06:27 PM
Mologen AG (MOLGF.PK): Initiation Of Phase 3 IMPALA Study With Immunotherapy MGN1703 In Colorectal 9/11/2014 9:52:11 AM
Mologen AG (MOLGF.PK): General Meeting Votes In Favour Of All Proposed Resolutions And Elects New Supervisory Board Members 8/15/2014 12:04:21 PM
Mologen AG (MOLGF.PK): Preparation And Launch Of New Studies Characterized The First Half-Year 2014 8/13/2014 1:01:20 PM
Mologen AG (MOLGF.PK): First Approvals For Phase III IMPALA Colorectal Cancer Study 8/4/2014 8:32:15 AM
123456789